Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q1 2022 · 10-Q
Revenue$1.18M$1.18M+17.6% vs Q1 2021 Net Income-$4.48M-$4.48MN/M vs Q1 2021 EPS, diluted—
Gross Profit$122,000+15.1% Operating Income-$4,486,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flow-$4,134,000N/M Free Cash Flowderived-$4,171,000N/M Margins · derivedGross margin10.3%−0.2 pt vs Q1 2021
Operating margin-379.2%−49.8 pt vs Q1 2021
Net margin-378.8%−56.4 pt vs Q1 2021
ended Mar 31, 2022 · filed May 9, 2022 · 39 d after period end